血清胱氨酸蛋白酶抑制剂C,SCysC
1)SCysC血清胱氨酸蛋白酶抑制剂C
1.Objective To investigate the relationship among urinary microalbumin excretion rate (UAER), serum cysteine protease inhibitor (SCysC), serum creatinine (SCr), serum β2 microglobulin (Sβ2MG), urinary immunoglobulin (UIgG), urinary β2 microglobulin (Uβ2MG), and creatinine clearance (Ccr), which were used for diagnosing early diabetic nephropathy (DN).目的探讨早期糖尿病肾病临床指标中尿微量清蛋白排泄率(UAER)与血清胱氨酸蛋白酶抑制剂C(SCysC)、血清肌酐(SCr)、血清β2微球蛋白(Sβ2MG)、尿免疫球蛋白G(UIgG)、尿β2微球蛋白(Uβ2MG)、内生肌酐清除率(Ccr)之间的关系。
英文短句/例句

1.The level and clinical significance of cystatin(CysC)in blood of diabetic patients糖尿病患者血清胱氨酸蛋白酶抑制剂C水平及临床意义
2.Clinnical Value of Serum Cystatin C to the Diagnosis of Kidney Damage;血清半胱氨酸蛋白酶抑制剂C检测对肾损害的临床价值
3.Serum Cystatin C as an Efficacious Marker of Renal Function in Kidney Transplant Recipients;血清半胱氨酸蛋白酶抑制剂C在肾移植术后肾功能监测中的应用
4.Contents of serum Cyst-C and urinary microalbumin in children with Henoch-Schonlein purpura过敏性紫癜患儿血清半胱氨酸蛋白酶抑制剂C和尿微量清蛋白检测的临床意义
5.To compare serum cystatin C and creatinine as an efficacious marker of renal function in kidney transplant recipients肾移植后在肾功能监测中血清半胱氨酸蛋白酶抑制剂C同血清肌酐的应用比较
6.Probing into the Diagnostic Significance of CystatinC on Early Damage of Diabetic Nephropathy;血半胱氨酸蛋白酶抑制剂C对早期糖尿病肾病诊断的探讨
7.Increased Plasma Cystatin C Level Is a Risk Factor for Cerebral Infarction血浆半胱氨酸蛋白酶抑制剂C水平与脑梗死的关系
8.Cystatin C,Kidney Function and Cardiovascular Disease半胱氨酸蛋白酶抑制剂C与肾功能和心血管疾病
9.The Relationship between Cystatin C and Coronary Heart Disease半胱氨酸蛋白酶抑制剂C与冠心病的关系
10.Clinical Study on Changes of Serum Cystatin C Level in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome阻塞性睡眠呼吸暂停低通气综合征患者血清半胱氨酸蛋白酶抑制剂C水平变化的临床研究
11.Surveying the Concentration of Serum Cystatin C and Establishing it's Reference Value in Zhanjiang Area Healthy Crowd湛江市健康人群血清半胱氨酸蛋白酶抑制剂C浓度的调查及参考值范围的建立
12.Applications of Cystatin C in the Field of Kidney Disease半胱氨酸蛋白酶抑制剂C在肾脏病领域应用进展
13.H-7 reduces cysteine protease activation in the rat model of focal cerebral ischemia蛋白激酶抑制剂H-7降低局灶性脑缺血半暗带和核心区半胱氨酸蛋白酶的活化
14.Recombinant Sv-cystatin Inhibits Tumor Invasion and Metastasis蛇毒半胱氨酸蛋白酶抑制剂(sv-cystatin)重组蛋白抗肿瘤侵袭转移作用
15.The Value of Cystatin C in Detecting the Early Damage of Graft Function after Renal Transplantation;半胱氨酸蛋白酶抑制剂C在肾移植术后移植物功能损伤早期检测中的应用价值探讨
16.The Evaluation and Comparison of Three Kinds of Measuring Methods for Cystatin C;半胱氨酸蛋白酶抑制剂C测定的检验程序验证及三种测定方法比较
17.The establishment of reference range of serum cystatin C and its value in the evaluation of renal function of diabetes patients半胱氨酸蛋白酶抑制剂C参考范围的设立及在糖尿病肾功能评价中的作用
18.The diagnosis's value of serum cystatin C in the elderly patients with type 2 diabetic early renal damage血清胱蛋白酶抑制剂C在老年2型糖尿病患者早期肾功能损害诊断中的价值
相关短句/例句

serum cystatin C血清半胱氨酸蛋白酶抑制剂C
1.Clinical application of serum cystatin C to evaluate glomerular filtration rate;应用血清半胱氨酸蛋白酶抑制剂C评价肾小球滤过功能的临床研究
2.Objective: To evaluate the applicability of serum cystatin C ,serum creatinine and urine microprotein as endogenous marker for detection of renal disfunction in patients with chronic kidney disease.目的探讨血清半胱氨酸蛋白酶抑制剂C (Cystatin C )、血清肌酐(Scr)及尿微量蛋白(α1-MG、ALB、TRF)在评价慢性肾脏病患者肾功能损害中的比较及血清CysC浓度判定在肾小球滤过功能中的临床价值。
3.Results:there was a significant difference of serum Cystatin C and CCr among the B、C、D three groups (P<0.目的:探讨血清半胱氨酸蛋白酶抑制剂C(CysC)水平检测对糖尿病早期肾功能损害的诊断意义。
3)Serum cystatin C血清胱蛋白酶抑制剂C
1.Objectives To evaluate the various markers of kidney function in asphyxiated neonates,especially the variation and values of serum Cystatin C and urine microprotein.目的探讨血清胱蛋白酶抑制剂C(Cystain C)、尿微量蛋白系列在窒息后新生儿中的变化及意义,评价新生儿肾功能的检测指标。
4)Cystatin C胱氨酸蛋白酶抑制剂C
1.Objective To evaluate Cystatin C in the evaluation of renal function of heart operation patients.目的评价胱氨酸蛋白酶抑制剂C(Cystatin C)在心脏手术患者肾功能评估的应用价值。
5)CystatinC半胱氨酸蛋白酶抑制 C
6)cystatin C血清胱蛋白酶抑制剂
延伸阅读

蛋白酶抑制剂分子式:CAS号:性质:从广义上指与蛋白酶分子活性中心上的一些基团结合,使蛋白酶活力下降,甚至消失,但不使酶蛋白变性的物质。从放线菌发酵液中分离到亮肽素、抗痛素、糜蛋白酶抑素、抑弹性蛋白酶醛、抑胃蛋白酶素、磷酰胺素等,能分别抑制胰蛋白酶、木瓜蛋白酶、糜蛋白酶、弹性蛋白酶、胃蛋白酶、金属蛋白酶等各种蛋白酶。都属于蛋白酶抑制剂。能减慢或完全停止某一酶促反应直接或间接地影响酶活性中心的作用。通常抑制作用可分为可逆性和不可逆性两大类。